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Abstract
Introduction Hypertrophy of the calvarium has different
aetiologies, among them the rare Proteus syndrome.
Case report We report here the case of a young girl initially
treated for relapsing right then left large chronic subdural
haematoma, who progressively developed craniofacial hy-
pertrophy consistent with the diagnosis of Proteus syn-
drome. Calvarium hypertrophy was shaved and remodelled
combining midface advancement, essentially for cosmetic
purposes. During the first calvarium remodelling, important
bleeding of the bone required large volume of blood replace-
ment. Haemostasis workup revealed platelets aggregation
anomalies. Bleeding issues during subsequent surgeries were
controlled with tranexamic acid and desmopressin acetate.
Discussion Other manifestations of Proteus syndrome, such
as a right hypertrophy of the face with hypoplasia of its
middle third, a pigmented epidermal nevus and asymmetric
limbs and scoliosis, appeared progressively over time.
Blood and fibroblast phosphatase and tensin homolog mu-
tation was not found.
Conclusion Literature review of operated patients with Pro-
teus syndrome did not reveal an association with platelets
anomalies. A complete haemostasis workup following this
unexpected haemorrhagic complication is recommended for
this rare pathology.
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Introduction
Proteus syndrome is a very rare condition, first described by
Cohen [11], and mostly diagnosed during the first decade of
life. It is thought that Joseph Merrick also known as the
“Elephant Man”, who lived in the late nineteenth century,
had the Proteus syndrome [20]. It is characterised by pro-
gressive, segmental overgrowth of various tissues, most
commonly affecting the skin, skeleton, adipose and central
nervous system.
The case of a child with macrocrania and subdural
haematomas as the initial presentation is discussed. The
haemostasis workup revealed platelets aggregation anomalies.
Case report
A 10-year-old child born from a Swiss father and Filipino
mother is reported. Pregnancy and delivery were uneventful.
At the age of 6 months, she suffered from a minor head trauma,
after falling from the changing table. At the age of 1 year, she
was referred for progressive macrocrania at the neurosurgical
outpatient clinic. At this time, head circumference was 53 cm
(above the 97th percentile). Her neurological and developmental
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examinations at this time were unremarkable. Silverman syn-
drome workup was negative.
Head CT and MRI showed a large right chronic subdural
haematoma (Fig. 1a), which was treated with a right
subduro-peritoneal shunt. A control CT scan 5 months later
revealed a chronic subdural haematoma on the opposite side
(Fig. 1b), which was also drained and shunted. A follow-up
CT scan 2 months after this last operation showed that the
haematomas were totally resolved.
The patient progressively developed over 1 year a grow-
ing firm and non-mobile frontal prominence which was
cosmetically disfiguring. The CT scan (Fig. 2a) showed a
bony thickness localised on the frontal bone, with intact
inner and outer table. There was no evidence of intracranial
extension or any compression of the brain. Retrospective
review of the initial CTs showed that the thickness of the
frontal bone was already abnormal and had increased with
time (Fig. 1a, b).
The hypertrophied bone was shaved and remodelled with
a high-speed burr, when she was 3 years old, allowing an
acceptable forehead. At the same time, the subduro-
peritoneal shunts were removed with the exception of the
intracranial part of the catheters that were adherent to the
brain. Shaving of the frontal bone was complicated by a
massive bleeding, requiring a blood transfusion and the
administration of tranexamic acid.
Haemostasis workup disclosed platelets dysfunction with
absence of aggregation after stimulation with epinephrine.
Genetic workup including blood and skin karyotypes, as
well as phosphatase and tensin homolog (PTEN) mutation
search in these two tissues, did not show any abnormality.
Histology of the removed bone showed a reactive aspect
of cancellous bone without evidence of fibrous dysplasia or
neoplasia. The patient recovered well after surgery and
remained neurologically normal. At 1-year follow-up, there
was no recurrent skull deformity.
The girl was also followed at the neuro-ophthalmologic
outpatient clinic for a right eye strabismus which was pres-
ent since birth. A right optic atrophy was also discovered at
diagnosis without any evidence of intracranial hypertension.
A lipodermoid of the right conjunctiva was excised at the
age of 3 years.
Overtime, the patient's phenotype changed. The right
hypertrophy of the face progressed with a broad nasal root
and a midfacial hypoplasia. Orthodontic examination
disclosed a chaotic implantation of the teeth, especially on
the left side, associated with a convex philtrum, a prominent
inferior lip and maxillary retrusion (Fig. 3a–c). A pigmented
epidermal naevus of the neck was diagnosed and a small
“café au lait” spot was described over the right flank
(Fig. 3d). The left hand had a trident aspect with a valgus
Fig. 1 a CT scan showing the initial right isodense chronic subdural
haematoma, delimited by white arrows. b CT scan showing the con-
tralateral subdural haematoma, delimited by white arrows. Note the
thickness of the frontal bone
Fig. 2 Lateral X-ray illustrating the frontal bossing
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of the thumb and a separation between the third and fourth
fingers (Fig. 3e). A 5-cm length difference between the legs
and a progressive scoliosis were also noted.
Formal neuropsychological testing at the age of 4 years
revealed a neurological development delay of 1 year, which
necessitated special education.
Unfortunately, the frontal prominence progressively
reappeared, with concomitant development of a progressive
maxillary retrusion. At the age of 9 years, a LeFort III
osteotomy was performed, and internal distractors were
applied. The frontal bone was again shaved at the age of
10 years, together with the removal of the distracters. To
prevent a recurrent haemorrhage, the patient was prepared
by administering desmopressin acetate (0.3 μg/kg) and
tranexamic acid preoperatively (10 mg/kg and 2 mg/kg/h)
during the surgery. The surgery was uneventful.
Discussion
Proteus syndrome is a very rare congenital overgrowth
condition with a prevalence lower than one in 1,000,000.
According to Legendre et al., only 205 cases have been
published in the world's literature, among them only 97
satisfy the recently published diagnosis criteria of Proteus
syndrome [19]. The phenotypic expression of this disorder
is highly variable and affect patients in a mosaic manner [6],
including osseous, vascular and skin modifications.
A workshop on Proteus syndrome was held in March
1998, at the National Institutes of Health (Bethesda, USA),
and participants developed recommendations for diagnostic
criteria, and the presented case meets these criteria [6].
Craniofacial hyperostosis is observed in patients with
Proteus syndrome in approximately 30 % of all cases [24,
26]. At the time of onset, hyperostosis is known to be
variable, but most of the manifestations occur during the
first year of life [1].
Limb deformities are a common feature of this syndrome;
these can vary from macrodactyly of a single digit to true
asymmetric gigantism of digits or toes [2].
Common vascular anomalies are lymphatic malformations,
haemangiomas and varicosities. Connective tissue naevi, epider-
mal naevi, pigmented naevi, subcutaneous hamartomatous tu-
mours and plantar skin hyperplasia are commonly reported [7,
24, 27]. Patients with a greater number of skin abnormalities tend
to have a greater number of extracutaneous abnormalities [23].
Brain anomalies are uncommon in this syndrome [12].
Intellectual impairment and seizures are also rare, being
observed in 20 and 13 % of patients, respectively. Among
those patients with intellectual impairment, 88 % have cra-
nial abnormalities. Hemimegalencephaly and concomitant
dilatation of the ipsilateral ventricle may be seen [14, 22].
Some authors report an asymmetry of the central nervous
system at both cerebral and brainstem levels, comparing
brainstem-, somato-sensorial and visual auditory-evoked
potentials [22]. Dandine et al. reported a case of Proteus
syndrome associated with a severe intracranial hypertension
which resolved after fronto-parietal craniectomy [12].
There are many differential diagnoses for the Proteus syn-
drome. The two disorders most commonly confusing are
Fig. 3 a–c Pictures taking at
the age of 5 showing a right
hypertrophy of the face with a
broad nasal root, mandibular
prognathisme and a chaotic
implantation of the teeth. d–f
Pictures showing a pigmented
naevus of the neck, left hand
deformation and left foot
hypertrophy
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Klippel–Trenaunay–Weber syndrome and hemihyperplasia/
lipomatosis syndrome [2, 6]. Klippel–Trenaunay–Weber syn-
drome is a vascular malformation involving lower or upper
limbs and/or trunk and is always combined with capillary,
venous and lymphatic malformations; the pigmentary lesions
are evident at birth or in early life. This syndrome is usually
more severe at birth than Proteus syndrome [2, 7, 17, 21].
Hemihyperplasia/lipomatosis syndrome is not associated with
connective tissue naevi, exostoses, linear naevi and deep
vascular malformations as seen in Proteus syndrome [17].
Encephalocraniocutaneous syndrome is generally local-
ised to the craniofacial areas and may be a localised form of
Proteus syndrome [2, 21]. In Maffucci syndrome, the vas-
cular anomalies are venous and occur with enchondromas
not found in Proteus syndrome [2, 17, 23].
Osteopetrosis is a heterogeneous group of rare inherited
disorders of the skeleton, caused by failure of osteoclast
development or function. The major neurological symptoms
are due to the restriction of skull foramina growth. There is a
varying amount of calvarial and skull base thickening that
occurs [15].
The PTEN tumour suppressor gene is a central negative
regulator of the PI3K/AKT signalling cascade that influ-
ences multiple cellular functions including cell growth, sur-
vival, proliferation and migration in a context-dependant
manner [9]. Proteus syndrome has recently been shown to
be caused by a somatic activating mutation in AKT1 [13,
20]. The association of Proteus syndrome with germ line
mutations of PTEN suppressor gene had previously been
reported by some authors [25, 28] but could not be con-
firmed by others [3, 6].
A literature review did not report any bleeding problem
in the Proteus syndrome. Hypercoagulopathy is noted in one
case reported by Dandine et al., as their patient presented a
pulmonary embolism and a left transverse sinus thrombosis
[12]. In the present case, a platelet aggregation test showed
an impaired responsiveness to epinephrine with normal
coagulogram. Even if a depressed responsiveness to epi-
nephrine in platelets from healthy subject has been reported,
this condition can explain the initial subdural haematomas
and the massive bleeding during the surgery [8, 16]. Anoth-
er explanation could be a disseminated intravascular
coagulopathy during surgery, but this does not explain the
initial haematomas. The administration of tranexamic acid
may be a useful adjunct in the medical treatment of high-risk
patients with Klippel–Trenaunay–Weber syndrome and oth-
er vascular naevi complicated by coagulopathy [18].
As the Proteus syndrome is progressive in character, the
craniofacial distortion typically increases with age. There is no
specific treatment. Simple corrective procedures might be
performed in early life. As the overgrowth in Proteus syn-
drome is relentless, major osteotomies should be performed
after completion of skeletal growth and might be repeated in
order to stabilise the symmetrical appearance of the craniofa-
cial skeleton [1, 4–6, 10, 23]. In localised forms, one can
consider a total replacement of the calvarium by heterologous
plasty.
Conclusion
To our knowledge, this is the first reported case of Proteus
syndrome with platelets anomalies. Further cases should be
collected for a better understanding of this association. In all
cases, a multidisciplinary approach is required, anaesthesi-
ologist team have to be aware for increased bleeding risk
and a complete haemostasis workup should be performed
before any surgery.
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